Related Topics News -

     
 Detail   |   Print 
     
翰森製藥阿美替尼重新遞交歐盟上市許可申請獲EMA受理
2026-10-12T  
世衛不建議10歲以下兒童使用減肥藥物
2026-10-07T  
《大行》美銀證券:亞太投資者會議AI主導討論 看好韓台記憶體及半導體
2026-09-29T  
《大行》摩通:默沙東/第一三共撤回B7-H3 ADC申請 對翰森製藥/GSK旗下Ris-Rez屬正面
2026-09-28T  
美銀:全球基金結束四年來對中國的「低配」策略
2026-09-28T  
翰森製藥阿美替尼歐盟上市許可遭撤銷 擬重新遞交申請
2026-09-28T  
翰森製藥HS-20093治療骨肉瘤上市許可申請獲受理
2026-09-25T  
《大行》交銀國際升翰森製藥目標價至46元 B7-H3 ADC優異數據閃耀WCLC
2026-09-24T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.